Mettler Toledo International (MTD) has wrapped up FY 2025 with fourth quarter revenue of US$1.1b and basic EPS of US$14.02, alongside trailing twelve month revenue of US$4.0b and EPS of US$42.17 that frame the latest numbers in a fuller yearlong context. Over recent quarters the company has seen revenue move from US$954.5m in Q3 2024 to US$1.0b in Q3 2025 and US$1.1b in Q4 2025, while quarterly EPS has tracked from US$10.01 to US$10.60 and then US$14.02. This sets up a picture where investors can focus on how steadily high margins and a 21.6% net profit margin on the trailing figures shape the quality of these results.

With the headline numbers on the table, the next step is to see how this margin profile and earnings trajectory line up with the widely followed narratives around Mettler Toledo, and where the fresh data might push those stories in a different direction.

Margins Hold Near 22% Despite Slight Compression

• Over the last 12 months, Mettler Toledo converted US$4.0b of revenue into US$869.2 million of net income, which works out to a 21.6% net margin compared with 22.3% the prior year.
• What stands out for a more bullish take is that this 21.6% margin sits alongside trailing EPS of US$42.17 and a five year EPS growth rate of 3.9% per year. This supports the idea of a resilient business model, even as the data also shows only 0.7% EPS growth over the last year, so the margin strength and the slower recent EPS trend need to be weighed together.

EPS Trend Is Steady Rather Than Fast Growing

• Looking at the trailing figures, EPS sits at US$42.17 with earnings up 0.7% over the past year and compounding at 3.9% per year over five years. This lines up with the mid single digit earnings growth profile in the data rather than a high growth story.
• Supporters who focus on consistency may point to the trailing US$4.0b revenue base and US$869.2 million of net income as evidence of a solid earnings engine. At the same time, the modest 0.7% earnings growth and slightly lower margin compared with 22.3% earlier in the period show that the upbeat angle of steady compounding is balanced by a slower recent pace than the roughly 7% annual earnings growth that forecasts in the data suggest.

Curious how other investors connect these steady but moderate trends to the long term story for Mettler Toledo? 📊 Read the full Mettler-Toledo International Consensus Narrative.

Valuation Premium and Debt Add a Caution Flag

• The shares trade at US$1,373.57 on a trailing P/E of 32.1x, above the 27x peer average and higher than a DCF fair value of US$1,007.75 in the data, while the balance sheet is flagged as having a high level of debt.
• Critics who take a more bearish view often focus on this combination of a P/E premium to peers, a price above the DCF fair value and the high debt level. The figures here give that argument some backing because the stock is priced above the US$1,007.75 DCF fair value and carries the debt risk, even though the same dataset also highlights a P/E that is lower than the 36.5x Life Sciences industry average, which tempers how extreme that bearish case looks.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Mettler-Toledo International's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

See What Else Is Out There

Mettler Toledo pairs only 0.7% EPS growth with a premium 32.1x P/E, slightly lower margins than before and a high debt load that could concern cautious investors.

If that mix of modest growth, rich pricing and balance sheet risk makes you uneasy, take a few minutes to scan 83 resilient stocks with low risk scores that prioritize financial resilience and potentially steadier sleep at night.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.